Bellevue Group Ag Genetron Holdings LTD Transaction History

Bellevue Group Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.28 - $2.4 $685,852 - $1.29 Million	-535,822 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.19 - $6.09 $410,219 - $1.14 Million	-187,315 Reduced 25.9%	535,822 $1.17 Million
Q2 2021 Aug 12, 2021	BUY	$17.9 - $23.29 $1.63 Million - $2.12 Million	91,050 Added 14.4%	723,137 $14.6 Million
Q1 2021 May 12, 2021	BUY	$13.71 - $30.64 $6.27 Million - $14 Million	457,238 Added 261.5%	632,087 $13.6 Million
Q4 2020 Feb 16, 2021	BUY	$9.31 - $14.0 $134,427 - $202,146	14,439 Added 9.0%	174,849 $2.45 Million
Q3 2020 Nov 16, 2020	BUY	$9.1 - $15.81 $549,731 - $955,082	60,410 Added 60.41%	160,410 $1.92 Million
Q2 2020 Aug 13, 2020	BUY	$11.29 - $16.0 $1.13 Million - $1.6 Million	100,000 New	100,000 $1.21 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.